These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 34090865)

  • 1. Nanomedicine-based strategies to target and modulate the tumor microenvironment.
    Mendes BB; Sousa DP; Conniot J; Conde J
    Trends Cancer; 2021 Sep; 7(9):847-862. PubMed ID: 34090865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ROS-Responsive Nanomedicine: Towards Targeting the Breast Tumor Microenvironment.
    Malla RR; Kamal MA
    Curr Med Chem; 2021; 28(28):5674-5698. PubMed ID: 33297907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organoids technology for advancing the clinical translation of cancer nanomedicine.
    Zhao DK; Liang J; Huang XY; Shen S; Wang J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1892. PubMed ID: 37088100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies targeting tumor immune and stromal microenvironment and their clinical relevance.
    Hu M; Huang L
    Adv Drug Deliv Rev; 2022 Apr; 183():114137. PubMed ID: 35143893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer nanomedicines harnessing tumor microenvironmental components.
    Li Y; Chen Z; Gu L; Duan Z; Pan D; Xu Z; Gong Q; Li Y; Zhu H; Luo K
    Expert Opin Drug Deliv; 2022 Apr; 19(4):337-354. PubMed ID: 35244503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remodeling tumor microenvironment with nanomedicines.
    Martin JD; Miyazaki T; Cabral H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Nov; 13(6):e1730. PubMed ID: 34124849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology as a Delivery Tool for Precision Cancer Therapies.
    Sharma B; Crist RM; Adiseshaiah PP
    AAPS J; 2017 Nov; 19(6):1632-1642. PubMed ID: 29019032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of intravital imaging in nanomedicine-assisted anti-cancer therapy.
    Lu L; Sun Y; Wan C; Hu Y; Lo PC; Lovell JF; Yang K; Jin H
    Curr Opin Biotechnol; 2021 Jun; 69():153-161. PubMed ID: 33476937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined cancer therapeutics-Tackling the complexity of the tumor microenvironment.
    Roma-Rodrigues C; Raposo LR; Valente R; Fernandes AR; Baptista PV
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1704. PubMed ID: 33565269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Tumor Microenvironment for Cancer Therapy.
    Roma-Rodrigues C; Mendes R; Baptista PV; Fernandes AR
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Abnormality-Oriented Nanomedicine Design.
    Zhou Q; Xiang J; Qiu N; Wang Y; Piao Y; Shao S; Tang J; Zhou Z; Shen Y
    Chem Rev; 2023 Sep; 123(18):10920-10989. PubMed ID: 37713432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory nanomedicine for colorectal cancer treatment: a landscape to be explored?
    Silveira MJ; Castro F; Oliveira MJ; Sarmento B
    Biomater Sci; 2021 May; 9(9):3228-3243. PubMed ID: 33949441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biopolymer-based tumor microenvironment-responsive nanomedicine for targeted cancer therapy.
    Jha A; Kumar M; Bharti K; Manjit M; Mishra B
    Nanomedicine (Lond); 2024 Mar; 19(7):633-651. PubMed ID: 38445583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-dimensional nanomaterials for tumor microenvironment modulation and anticancer therapy.
    Wu M; Niu X; Zhang R; Ping Xu Z
    Adv Drug Deliv Rev; 2022 Aug; 187():114360. PubMed ID: 35636568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicine Strategies to Circumvent Intratumor Extracellular Matrix Barriers for Cancer Therapy.
    Xu X; Wu Y; Qian X; Wang Y; Wang J; Li J; Li Y; Zhang Z
    Adv Healthc Mater; 2022 Jan; 11(1):e2101428. PubMed ID: 34706400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal barriers to nanomedicine penetration in the pancreatic tumor microenvironment.
    Tanaka HY; Kano MR
    Cancer Sci; 2018 Jul; 109(7):2085-2092. PubMed ID: 29737600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-Incorporated Nanomedicines for Cancer Therapy.
    Wu SY; Wu FG; Chen X
    Adv Mater; 2022 Jun; 34(24):e2109210. PubMed ID: 35142395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boosting Nanomedicine Efficacy with Hyperbaric Oxygen Therapy.
    Wang X; Li S; Liu X; Wu X; Ye N; Yang X; Li Z
    Adv Exp Med Biol; 2021; 1295():77-95. PubMed ID: 33543456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines.
    Balasubramanian V; Liu Z; Hirvonen J; Santos HA
    Adv Healthc Mater; 2018 Jan; 7(1):. PubMed ID: 28570787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicines Targeting the Tumor Microenvironment.
    Tong R; Langer R
    Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.